| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910891230203321 |
|
|
Titolo |
Indicators of industry and services = : Indicateurs de l'industrie et des services |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Paris, : Organisation for Economic Co-operation and Development, ©2001-©2002 |
|
|
|
|
|
|
|
|
|
ISSN |
|
|
|
|
|
|
Descrizione fisica |
|
|
|
|
|
|
Collana |
|
Statistics = Statistiques |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Industrial statistics |
Service industries |
Statistiques industrielles |
Services (Industrie) |
Economische ontwikkeling |
Industriekonjunktur |
OECD-Staaten |
G-7-Staaten |
Nordamerika |
Europa |
EU-Staaten |
Periodicals. |
Statistics. |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Periodico |
|
|
|
|
|
|
|
|
|
|
|
|
2. |
Record Nr. |
UNINA9911019983503321 |
|
|
Titolo |
Evidence-based hematology / / edited by Mark A. Crowther ... [et al.] |
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Chichester, UK ; ; Hoboken, NJ, : Wiley-Blackwell, 2008 |
|
|
|
|
|
|
|
ISBN |
|
9786612684951 |
9781282684959 |
1282684957 |
9781444300857 |
1444300857 |
9781444300864 |
1444300865 |
|
|
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (440 p.) |
|
|
|
|
|
|
Collana |
|
|
|
|
|
|
Altri autori (Persone) |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Blood - Diseases |
Hematology |
Evidence-based medicine |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references and index. |
|
|
|
|
|
|
Nota di contenuto |
|
Contents; List of Contributors; Preface; Part 1 A Guide to the Evidence; 1 Rating the Quality of Evidence and Making Recommendations; 2 An Overview of Systematic Reviews; 3 Interpreting Results in Clinical Research; 4 Finding the Evidence in Hematology; 5 Applying EBM in Clinical Practice; 6 Using Evidence to Guide the Diagnosis of Disease; Part 2 Hemostasis and Thrombosis; 7 Diagnosis of Deep Vein Thrombosis; 8 The Diagnosis of Acute Pulmonary Embolism; 9 Initial Therapy of Deep Vein Thrombosis and Pulmonary Embolism; 10 Long-Term Anticoagulation in Venous Thromboembolism |
11 Thrombolytic Therapy for Deep Vein Thrombosis and Pulmonary Embolism12 Inferior Vena Cava Interruption; 13 Management of Venous Thromboembolism in Pregnancy; 14 Pediatric Thrombosis; 15 Bridging Anticoagulation in Patients Who Require Temporary Interruption of Warfarin for Surgery; 16 Evidence-based Approach to the Diagnosis and Management of Thrombotic Thrombocytopenic Purpura; 17 Diagnosis |
|
|
|
|
|
|
|
|
|
|
|
and Management of Disseminated Intravascular Coagulation; 18 Diagnosis and Management of Hereditary Bleeding Disorders; 19 Diagnosis and Management of Acquired Bleeding Disorders |
20 Diagnosis and Management of Heparin-Induced Thrombocytopenia21 Management of Antiphospholipid Antibody Syndrome; Part 3 Benign Hematologic Disorders; 22 Clinical Questions in Iron Overload; 23 Aplastic Anemia, Paroxysmal Nocturnal Hemoglobinuria, and Pure Red Cell Aplasia; 24 Acquired Anemias; 25 Immune Thrombocytopenic Purpura; 26 Neutropenia; 27 Hypereosinophilia; 28 Porphyrias; 29 Membrane and Enzyme Abnormalities of the Erythrocyte; 30 Sickle Cell Disease; 31 Evidence-based Treatment of Thalassemia Major; Part 4 Malignant Hematologic Disorders; 32 Acute Lymphoblastic Leukemia in Adults |
33 Acute Myeloid Leukemia in Adults34 Acute Myeloid Leukemia in Adults; 35 Current Areas of Controversy in the Treatment of Patients With Newly Diagnosed Acute Promyelocytic Leukemia; 36 Chronic Lymphocytic Leukemia; 37 Chronic Myeloid Leukemia; 38 Selected Management of Patients with Myelodysplastic Syndromes; 39 Evidence-based Treatment of Burkitt Lymphoma in Adults; 40 Primary Central Nervous System Lymphoma; 41 Diffuse Large B-cell Lymphoma; 42 Follicular Lymphoma; 43 Lymphoblastic Lymphoma; 44 Mantle Cell Lymphoma; 45 Management of Patients with Peripheral T-cell Lymphoma |
46 Selected Management Issues of Patients with Hodgkin Lymphoma47 Lymphocyte Predominant Hodgkin Lymphoma; 48 Management of Patients with Essential Thrombocythemia; 49 Management of Patients with Polycythemia Vera; 50 Evidence-based Review of Therapies in Multiple Myeloma; 51 Management of Waldenstrom's Macroglobulinemia; 52 The Role of Hematopoietic Growth Factors in Managing Patients with Hematologic Malignancies; Index |
|
|
|
|
|
|
Sommario/riassunto |
|
This unique new book uses a series of focussed questions, comprehensive literature evaluations and structured grades of recommendation to provide evidence for the treatment of hematological disorders, both malignant and benign. With contributions from leading international experts who have a real understanding of evidence-based medicine the book provides comprehensive reviews accompanied by clinical commentaries and recommendations on the best treatment regimes to adopt for individual patients.The book is split into two sections: the first examines the methodology underlying evidence b |
|
|
|
|
|
|
|
| |